The goal of this program is to improve management of non-small cell lung cancer (NSCLC) with new systemic therapies. After hearing and assimilating this program, the clinician will be better able to:Appraise the role of neoadjuvant and adjuvant immune checkpoint inhibitors for treating localized NSCLC.Identify the standard of care for localized EGFR-mutated NSCLC.Compare outcomes of amivantamab plus lazertinib therapy with osimertinib monotherapy for advanced EGFR-mutated NSCLC.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 903 Queens Lane
Pricing
CME included with membership · $1,095/yr
| Platinum Membership | $1,095/yr |
Collected from the provider’s public pages · source
Specialties served/covered
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Breast Imaging
- Cardiac Anesthesia
- Cardiovascular Disease
- Clinical Cardiac Electrophysiology
- Critical Care Medicine
- Diagnostic Radiology
- Endocrinology, Diabetes & Metabolism
- Facial Plastic & Reconstructive Surgery
- Gastroenterology
- General Internal Medicine
- General Operative Anesthesia
- General Otolaryngology
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Head & Neck Surgery
- Hematology
- Hospice & Palliative Medicine
- Hospital Medicine
- Interventional Radiology
- Laryngology
- Medical Oncology
- Neonatal-Perinatal Medicine
- Nephrology
- Neuro Anesthesia
- Neurocritical Care
- Neurodevelopmental Disabilities
- Neuroradiology
- Nuclear Medicine
- Obstetric Anesthesia
- Otology & Neurotology
- Pain Medicine
- Pediatric Anesthesia
- Pediatric Cardiology
- Pediatric Critical Care Medicine
- Pediatric Emergency Medicine
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pediatric Otolaryngology
- Pediatric Radiology
- Pediatric Surgery
- Primary Care Sports Medicine
- Pulmonary Disease
- Regional Anesthesia & Acute Pain
- Rheumatology
- Rhinology
- Sleep Medicine
- Surgical Critical Care
- Surgical Oncology
- Thoracic Anesthesia
- Trauma Surgery
- Vascular Surgery
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pain & Palliative
- Pediatrics
- Primary care
- Radiology
- Sports & Exercise Medicine
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Membership pricing — $1,095 / year
This provider prices CME through membership. Individual courses may also be sold separately.
See plans on audio-digest.orgListed by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Membership pricing
-
ReleasedSep 1, 2026
-
Last day to claim creditNov 23, 2028 2 years left
-
Learner’s Digest International (TM) New Systemic Therapies for Non-Small Cell Lung Cancer/Prostate Cancer Screening and Detection/Radiotherapy for Small Ren
-
Learner’s Digest International (TM) Neoadjuvant Strategies in Resectable Early-Stage Non-Small Cell Lung Cancer
-
Learner’s Digest International (TM) Resectable Early-Stage Non-Small Cell Lung Cancer/Breast Cancer
-
National Comprehensive Cancer Network Systemic Therapy in Early-Stage, Wild-Type Non-Small Cell Lung Cancer: Current Standards and Practical Applications
-
PRIME Education, Inc. (PRIME®) Novel Immunotherapy-Based Combination Approaches in Advanced NSCLC: Expanding Options for Durable Outcomes
-
Answers in CME Inc. (AiCME) A Blueprint for Action: Integrating Pre- and/or Post-Operative Immunotherapy Into Early-Stage NSCLC Management
